Is this D vitamin to worry about? Vitamin D insufficiency in an inpatient sample

References

• Inderjeeth CA, Nicklason F, Al-Lahham Y, et al. Vitamin D deficiency and secondary hyperparathyroidism: clinical and biochemical associations in older non-institutionalised Southern Tasmanians. Aust N Z J Med 2000; 30: 209–214
   PubMedGoogle Scholar
• Pasco JA, Henry MJ, Nicholson GC, Sanders KM, Kotowicz MA. Vitamin D status of women in the Geelong Osteoporosis Study: association with diet and casual exposure to sunlight. Med J Aust 2001; 175: 401–405
   PubMed Web of Science ®Google Scholar
• Diamond TH, Eisman JA, Mason RS, et al. Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med J Aust 2005; 182: 281–285
   PubMed Web of Science ®Google Scholar
• Berk M, Sanders KM, Pasco JA, et al. Vitamin D deficiency may play a role in depression. Med Hypotheses 2007; 69: 1316–1319
   PubMed Web of Science ®Google Scholar
• Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry 2006; 14: 1032–1040
   PubMed Web of Science ®Google Scholar
• Jorde R, Waterloo K, Saleh F, Haug E, Svartberg J. Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromso study. J Neurol 2006; 253: 464–470
   PubMed Web of Science ®Google Scholar
• Armstrong DJ, Meenagh GK, Bickle I, Lee AS, Curran ES, Finch MB. Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clin Rheumatol 2007; 26: 551–554
   PubMed Web of Science ®Google Scholar
• Schneider B, Weber B, Frensch A, Stein J, Fritz J. Vitamin D in schizophrenia, major depression and alcoholism. J Neural Transm 2000; 107: 839–842
   PubMed Web of Science ®Google Scholar
• Hoogendijk WJ, Lips P, Dik MG, Deeg DJ, Beekman AT, Penninx BW. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry 2008; 65: 508–512
   PubMed Web of Science ®Google Scholar
• Rosenthal NE, Sack DA, Skwerer RG, Jacobsen FM, Wehr TA. Phototherapy for seasonal affective disorder. J Biol Rhythms 1988; 3: 101–120
   PubMed Web of Science ®Google Scholar
• Gloth FM III, Alam W, Hollis B. Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. J Nutr Health Aging 1999; 3: 5–7
   PubMedGoogle Scholar
• Lansdowne AT, Provost SC. Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology (Berl) 1998; 135: 319–323
   PubMed Web of Science ®Google Scholar
• Dumville JC, Miles JN, Porthouse J, Cockayne S, Saxon L, King C. Can vitamin D supplementation prevent winter-time blues? A randomised trial among older women. J Nutr Health Aging 2006; 10: 151–153
   PubMed Web of Science ®Google Scholar
• Burne TH, Johnston AN, McGrath JJ, Mackay-Sim A. Swimming behaviour and post-swimming activity in vitamin D receptor knockout mice. Brain Res Bull 2006; 69: 74–78
   PubMed Web of Science ®Google Scholar
• Minasyan A, Keisala T, Lou YR, Kalueff AV, Tuohimaa P. Neophobia, sensory and cognitive functions, and hedonic responses in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol 2007; 104: 274–280
   PubMed Web of Science ®Google Scholar
• Pasco JA, Henry MJ, Kotowicz MA, et al. Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: the Geelong Osteoporosis Study. J Bone Miner Res 2004; 19: 752–758
   PubMed Web of Science ®Google Scholar
• Williams LJ, Henry MJ, Berk M, et al. Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression. Int Clin Psychopharmacol 2008; 23: 84–87
   PubMed Web of Science ®Google Scholar
• Henry MJ, Pasco JA, Nicholson GC, Seeman E, Kotowicz MA. Prevalence of osteoporosis in Australian women: Geelong Osteoporosis Study. J Clin Densitom 2000; 3: 261–268
   PubMed Web of Science ®Google Scholar
• Pasco JA, Jacka FN, Williams LJ, et al. Leptin in depressed women: cross-sectional and longitudinal data from an epidemiologic study. J Affect Disord 2008; 107: 221–225
   PubMed Web of Science ®Google Scholar
• Pasco JA, Henry MJ, Sanders KM, Kotowicz MA, Seeman E, Nicholson GC. Beta-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong Osteoporosis Study. J Bone Miner Res 2004; 19: 19–24
   PubMed Web of Science ®Google Scholar
• Eagles JM. Seasonal affective disorder. Br J Psychiatry 2003; 182: 174–176
   PubMed Web of Science ®Google Scholar
• Wehr TA. Photoperiodism in humans and other primates: evidence and implications. J Biol Rhythms 2001; 16: 348–364
   PubMed Web of Science ®Google Scholar
• Lam RW, Levitan RD. Pathophysiology of seasonal affective disorder: a review. J Psychiatry Neurosci 2000; 25: 469–480
   PubMed Web of Science ®Google Scholar
• Bernstein HG, Heinemann A, Krell D, et al. Hypothalamic nitric oxide synthase in affective disorder: focus on the suprachiasmatic nucleus. Cell Mol Biol (Noisy-le-grand) 2005; 51: 279–284
   PubMed Web of Science ®Google Scholar
• Kalsbeek A, van Heerikhuize JJ, Wortel J, Buijs RM. Restricted daytime feeding modifies suprachiasmatic nucleus vasopressin release in rats. J Biol Rhythms 1998; 13: 18–29
   PubMed Web of Science ®Google Scholar
• Obradovic D, Gronemeyer H, Lutz B, Rein T. Cross-talk of vitamin D and glucocorticoids in hippocampal cells. J Neurochem 2006; 96: 500–509
   PubMed Web of Science ®Google Scholar
• Yin L, Wang J, Klein PS, Lazar MA. Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock. Science 2006; 311: 1002–1005
   PubMed Web of Science ®Google Scholar
• Roybal K, Theobold D, Graham A, et al. Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci USA 2007; 104: 6406–6411
   PubMed Web of Science ®Google Scholar
• Watson LC, Marx CE. New onset of neuropsychiatric symptoms in the elderly: possible primary hyperparathyroidism. Psychosomatics 2002; 43: 413–417
   PubMed Web of Science ®Google Scholar
• McCann JC, Ames BN. Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction?. FASEB J 2008; 22: 982–1001
   PubMed Web of Science ®Google Scholar
• Berk M, Ng F, Dean O, Dodd S, Bush AI. Glutathione: a novel treatment target in psychiatry. Trends Pharmacol Sci 2008; 29: 346–351
   PubMed Web of Science ®Google Scholar
• Stumpf WE, O'Brien LP. 1,25 (OH)2 vitamin D3 sites of action in the brain. An autoradiographic study. Histochemistry 1987; 87: 393–406
   PubMedGoogle Scholar
• Stumpf WE. Vitamin D sites and mechanisms of action: a histochemical perspective. Reflections on the utility of autoradiography and cytopharmacology for drug targeting. Histochem Cell Biol 1995; 104: 417–427
   PubMed Web of Science ®Google Scholar
• Wion D, MacGrogan D, Neveu I, Jehan F, Houlgatte R, Brachet P. 1,25-Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis. J Neurosci Res 1991; 28: 110–114
   PubMed Web of Science ®Google Scholar
• Beekman AT, Copeland JR, Prince MJ. Review of community prevalence of depression in later life. Br J Psychiatry 1999; 174: 307–311
   PubMed Web of Science ®Google Scholar
• Jacka FN, Pasco JA, Henry MJ, et al. Depression and bone mineral density in a community sample of perimenopausal women: Geelong Osteoporosis Study. Menopause 2005; 12: 88–91
   PubMed Web of Science ®Google Scholar
• Jacka FN, Pasco JA, Henry MJ, et al. Depression and bone mineral density in a community sample of men: Geelong Osteoporosis Study. J Mens Health Gender 2007; 4: 292–297
   Google Scholar
• Williams L, Pasco JA, Jacka FN, Henry M, Dodd S, Berk M. Depression and bone metabolism: a review. Psychother Psychosom 2008; in press.
   Google Scholar